共 50 条
PROCEDURAL ISSUES IN HEALTH TECHNOLOGY ASSESSMENT (HTA) FOR RE-PRICING IN JAPAN
被引:0
|作者:
Igarashi, A.
[1
]
Aranishi, T.
[2
]
Nakajima, A.
[3
]
Sakai, H.
[4
]
Naoi, I
[5
]
Atsumi, J.
[6
]
Okuyama, K.
[7
]
Azuma, M. K.
[4
]
Machida, M.
[8
]
Yoshida, M.
[9
]
Nojima, T.
[10
]
Kawata, Y.
[11
]
机构:
[1] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
[2] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[3] Teijin Pharma Ltd, Tokyo, Japan
[4] Eisai & Co Ltd, Tokyo, Japan
[5] Sumitomo Pharma Co Ltd, Chuo Ku, Osaka 13, Japan
[6] Toray Industries Ltd, Tokyo, Japan
[7] MSD KK, Tokyo, Japan
[8] Shionogi & Co Ltd, Osaka, Japan
[9] Pfizer R&D Japan GK, Tokyo, Japan
[10] Kowa Co Ltd, Tokyo, Japan
[11] Chugai Pharmaceut Co Ltd, Tokyo, Japan
关键词:
D O I:
暂无
中图分类号:
F [经济];
学科分类号:
02 ;
摘要:
HTA126
引用
收藏
页码:S320 / S321
页数:2
相关论文